These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 27034792)
21. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma. Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615 [TBL] [Abstract][Full Text] [Related]
22. Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data. Opfermann KJ; Wahlquist AE; Garrett-Mayer E; Shridhar R; Cannick L; Marshall DT Am J Clin Oncol; 2014 Apr; 37(2):112-6. PubMed ID: 23211221 [TBL] [Abstract][Full Text] [Related]
23. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217 [TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits? Merchant NB; Rymer J; Koehler EA; Ayers GD; Castellanos J; Kooby DA; Weber SH; Cho CS; Schmidt CM; Nakeeb A; Matos JM; Scoggins CR; Martin RC; Kim HJ; Ahmad SA; Chu CK; McClaine R; Bednarski BK; Staley CA; Sharp K; Parikh AA J Am Coll Surg; 2009 May; 208(5):829-38; discussion 838-41. PubMed ID: 19476845 [TBL] [Abstract][Full Text] [Related]
25. Cancer statistics, 2014. Siegel R; Ma J; Zou Z; Jemal A CA Cancer J Clin; 2014; 64(1):9-29. PubMed ID: 24399786 [TBL] [Abstract][Full Text] [Related]
26. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Jang JY; Kang MJ; Heo JS; Choi SH; Choi DW; Park SJ; Han SS; Yoon DS; Yu HC; Kang KJ; Kim SG; Kim SW Ann Surg; 2014 Apr; 259(4):656-64. PubMed ID: 24368638 [TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of the efficacy of pancreatoduodenectomy with extended lymphadenectomy in the treatment of pancreatic cancer. Xu X; Zhang H; Zhou P; Chen L World J Surg Oncol; 2013 Dec; 11():311. PubMed ID: 24321394 [TBL] [Abstract][Full Text] [Related]
29. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366 [TBL] [Abstract][Full Text] [Related]
30. Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin. Campbell F; Smith RA; Whelan P; Sutton R; Raraty M; Neoptolemos JP; Ghaneh P Histopathology; 2009 Sep; 55(3):277-83. PubMed ID: 19723142 [TBL] [Abstract][Full Text] [Related]
31. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101 [TBL] [Abstract][Full Text] [Related]
33. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. Herman JM; Swartz MJ; Hsu CC; Winter J; Pawlik TM; Sugar E; Robinson R; Laheru DA; Jaffee E; Hruban RH; Campbell KA; Wolfgang CL; Asrari F; Donehower R; Hidalgo M; Diaz LA; Yeo C; Cameron JL; Schulick RD; Abrams R J Clin Oncol; 2008 Jul; 26(21):3503-10. PubMed ID: 18640931 [TBL] [Abstract][Full Text] [Related]
34. Most pancreatic cancer resections are R1 resections. Esposito I; Kleeff J; Bergmann F; Reiser C; Herpel E; Friess H; Schirmacher P; Büchler MW Ann Surg Oncol; 2008 Jun; 15(6):1651-60. PubMed ID: 18351300 [TBL] [Abstract][Full Text] [Related]
35. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Smeenk HG; van Eijck CH; Hop WC; Erdmann J; Tran KC; Debois M; van Cutsem E; van Dekken H; Klinkenbijl JH; Jeekel J Ann Surg; 2007 Nov; 246(5):734-40. PubMed ID: 17968163 [TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. House MG; Gönen M; Jarnagin WR; D'Angelica M; DeMatteo RP; Fong Y; Brennan MF; Allen PJ J Gastrointest Surg; 2007 Nov; 11(11):1549-55. PubMed ID: 17786531 [TBL] [Abstract][Full Text] [Related]
38. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Bilimoria KY; Bentrem DJ; Ko CY; Ritchey J; Stewart AK; Winchester DP; Talamonti MS Cancer; 2007 Aug; 110(4):738-44. PubMed ID: 17580363 [TBL] [Abstract][Full Text] [Related]
39. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations. Meriggi F; Gramigna P; Forni E Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320 [TBL] [Abstract][Full Text] [Related]
40. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Michalski CW; Kleeff J; Wente MN; Diener MK; Büchler MW; Friess H Br J Surg; 2007 Mar; 94(3):265-73. PubMed ID: 17318801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]